TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HVIVO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

HVIVO

ST13

US500000079169697

Class

5, 35, 42

Filing

79169697

Registration

5815659

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

06/16/2026

Classification

Registered

Trademark type

Combined

Nice classes

5, 35, 42

Filing date

05/01/2015

Registration date

07/30/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/22/2026

Last transaction

06/16/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

London, GB

Examiner

TOY, JOSHUA SPENCER JOLL

Current location

Historical data usage

Mark description

The mark consists of the following: a black, stylized letter "h" and green letters "VIVO" in standard characters. The white background in the drawing represents background areas, and the color white is not a part of the mark.

Holders and representatives

Holders

HVIVO SERVICES LIMITED
HVIVO SERVICES LIMITED

Representatives

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 5Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

[ Pharmaceutical and medical compositions for human and/or veterinary use, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; diagnostic preparations and substances for medical purposes; medical diagnostic reagents; antiserums for diagnostic purposes for medical purposes; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical reagents for medical, pharmaceutical and veterinary purposes; viruses for the treatment of humans and/or animals, namely, viruses for use as an ingredient in vaccines for preventing and treatment of influenza or HRV or RSV; diagnostic preparations for medical purposes; in-vitro diagnostic reagents for medical purposes; in-vivo reagents for diagnostic medical purposes ]

Class 35

Business investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemization and compilation of medical information into computer databases; providing statistical information for business purposes, all of said information relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; registration services for diagnostic testing, namely, services consisting of the registration, collection, transcription, compilation and systemization of written communications and data with respect to diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management services, including information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medical, health or clinical care; collation and provision of business information regarding results from diagnostic testing in relation to medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medical, hospital, insurance or billing records

Class 42

Medical research services; conducting clinical trials for others; medical research laboratory services; scientific analysis and research services, namely scientific research; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical and health care research services in the field of clinical testing services, physician testing services for assisting pharmacists, pharmacy testing services, medical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold; research services in the field of medical diagnostics; medical laboratory services for the analysis of samples taken from patients for research purposes

Publications

History of USPTO decisions and trademark events.

47 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

05/22/2026

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

05/22/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/18/2026

ES71

TEAS SECTION 71 RECEIVED

01/20/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/01/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/30/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/30/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/06/2019

FIMP

FINAL DISPOSITION PROCESSED

11/06/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/30/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/30/2019

GPNX

NOTIFICATION PROCESSED BY IB

05/31/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/14/2019

PUBO

PUBLISHED FOR OPPOSITION

05/14/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/09/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/24/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/24/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/24/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/02/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/21/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/21/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/21/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

11/02/2018

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

05/01/2018

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

10/20/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

04/19/2017

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/20/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/04/2017

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/04/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

10/13/2016

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

04/07/2016

ALIE

ASSIGNED TO LIE

03/22/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/22/2015

GNSL

LETTER OF SUSPENSION E-MAILED

09/22/2015

CNSL

SUSPENSION LETTER WRITTEN

09/22/2015

RFNT

REFUSAL PROCESSED BY IB

09/18/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/18/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/17/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/17/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/27/2015

RFRR

REFUSAL PROCESSED BY MPU

08/27/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/27/2015

CNRT

NON-FINAL ACTION WRITTEN

08/26/2015

DOCK

ASSIGNED TO EXAMINER

08/13/2015

MAFR

APPLICATION FILING RECEIPT MAILED

08/11/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/06/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/30/2015

Continuous trademark protection

Get notified about every new filing that threatens HVIVO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.